Indeed, Buerger et al. have observed dilated cardiomyopathy in MHC-Cre+ mice, further highlighting a potential deleterious effect of the Cre recombinase under the control of the MHC promoter14. This evidence concerns the gene HLA-C and dilated cardiomyopathy.